Sanford Health, a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device. On August 14, 2009, the FDA gave 510(k) clearance to the Asfora Bullet Cage, a product which is designed for use in posterior lumbar interbody fusion surgeries to treat degenerative disc disease. The Asfora Bullet Cage will be manufactured and sold by Medical Designs, LLC, a Sioux Falls company owned by Dr. Asfora.
"We congratulate Dr. Asfora on the FDA approval of his spinal implant," said Dave Link, Sanford Health Executive Vice President. "At Sanford Health, our goal is to foster an environment which supports the efforts of our physicians to develop innovative solutions for the global health care market."
Commenting on the FDA approval, Dr. Asfora said, "The 510(k) clearance of the Asfora Bullet Cage represents the culmination of a decade of clinical research. Clinical experience to date demonstrates up to a 98 percent rate of interbody fusion of one or two levels in hundreds of cases using simply locally harvested bone without unexpected complications and without the use of pedicle screws and Bone Morphogenic Protein."
Dr. Asfora currently serves as a Neurosurgeon at Sanford Clinic in Sioux Falls. He specializes in adult and pediatric neurosurgery, spine surgery, brain tumor surgery, cerebrovascular surgery, peripheral nerve surgery, radiosurgery and functional neurosurgery including Deep Brain Stimulation for Movement Disorders. Dr. Asfora is board certified with the American Board of Neurological Surgery and the Royal College of Physicians and Surgeons of Canada. Dr. Asfora has been with Sanford Health since 2007 and has worked as a Neurosurgeon since 1989.
Scientists discover brain circuit for voluntary breathing control